Granzyme b inhibitor
Granzyme b inhibitor has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest paper, Feb 23, 2026: “Granzyme B from mast cells contributes to choroidal neovascularization in a model of wet age-related macular degeneration”.
See all 1 papers on granzyme b inhibitor
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
Mice: a single group. Cells, worms or flies and humans: nothing yet.
- 1 lab in 1 country
- Funders: Gouvernement du Canada | Canadian Institutes of Health Research and 1 more
- 1 of 1 finding with company ties
- Animals1
What did studies of granzyme b inhibitor find?
1Studies of granzyme b inhibitor measured 1 outcome; the most studied are angiogenesis (1 study).
Angiogenesis
downin mice1
1 study
Angiogenesis
downin mice1
Granzyme b inhibitor inhibits angiogenesis in mice (ex vivo choroidal sprouting assay).
“Both GzmB inhibition and mast cell stabilization suppressed angiogenic events”
Animalsex vivo choroidal sprouting assaychoroid
Frontiers in immunology
Latest
1 paper in 12 monthsFrontiers in Immunology
Granzyme B from mast cells contributes to choroidal neovascularization in a model of wet age-related macular degeneration
Experiments in animalsEye